SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Remedy Taking a hit why? -- Ignore unavailable to you. Want to Upgrade?


To: Clam Clam who wrote (425)1/7/1998 11:41:00 PM
From: Shege Dambanza  Read Replies (2) | Respond to of 763
 
Damn we're good. ;-)

Most investors lump RMDY with SCOP/CLFY/VNTV (I don't). The fact that SCOP and CLFY announced revenue growth has got to be a negative for RMDY. A little lower and even I may buy me some.



To: Clam Clam who wrote (425)1/14/1998 10:01:00 AM
From: Shege Dambanza  Respond to of 763
 
Interesting article in today's WSJ (page c19, Inside Track) on recent insider trading. It appears that Remedy has been successful in selling the spin that revenue shortfalls are primarily due to IBM's acquisition of SWRT.

Doesn't say much for the analysts who follow the stock.